RESCHEDULING HYDROCODONE COMBINATION PRODUCTS- ASSESSING THE IMPACT ON OPIOID UTILIZATION
Author(s)
Hatfield MD1, Sansgiry SS1, Johnson ML1, Essien EJ1, Todd KH2, Fleming ML1
1University of Houston, Houston, TX, USA, 2The University of Texas MD Anderson Cancer Center, Houston, TX, USA
OBJECTIVES: Hydrocodone combination products (HCPs) were the most prescribed drugs in the US in 2012. HCPs were rescheduled from C-III to C-II beginning October 6, 2014. Physicians and pharmacists have expressed concerns about the impact rescheduling could have on patient care. Additionally, Texas and Louisiana have many differences in prescribing regulations which may impact patient care, specifically regarding C-II prescribing. The objective of this study was to assess the impact of rescheduling HCPs on the utilization of opioid pain relievers (OPRs) in Texas and Louisiana. METHODS: A retrospective cohort design was employed using data from the Texas and Louisiana prescription drug monitoring programs (PDMPs), consisting of prescription level information for all C-II to C-V drugs dispensed from community pharmacy settings from June 1, 2013 to April 8, 2015. Interrupted time-series analysis was conducted on total OPR volume (i.e., morphine milligram equivalents) dispensed on a weekly basis within four categories: HCPs, C-II OPRs, acetaminophen with codeine, and tramadol by state. RESULTS: The final cohort contained 38,163,347 OPR prescriptions in Texas and Louisiana, of which 78.9% were from Texas. Volume of HCPs declined 955 mg/week (-45.1%, p<0.05) in Texas and declined 132 mg/week (-23.7%, p<0.05) in Louisiana post-rescheduling. Volume of C-II OPRs increased 20,007 mg/week (75.4%, p<0.05) in Texas and increased 10,523 mg/week (6.0%, p<0.05) in Louisiana post-rescheduling. Acetaminophen with codeine volume increased 58,539 mg/week (62.2%, p<0.05) in Texas and increased 3,889 mg/week (8.6%, p<0.05) in Louisiana post-rescheduling. Volume for tramadol increased 757,322 mg/week (1,073.3%, p<0.05) in Texas and remained unchanged (-1.5%, p=0.68) in Louisiana post-rescheduling. CONCLUSIONS: Rescheduling HCPs resulted in decreased volume of HCPs, increased volume of C-II OPRs, increased volume of acetaminophen with codeine, and increased volume of tramadol in Texas (up to levels comparable to Louisiana). Pain management using OPRs changed significantly due to rescheduling within these two states.
Conference/Value in Health Info
2016-05, ISPOR 2016, Washington DC, USA
Value in Health, Vol. 19, No. 3 (May 2016)
Code
PSY81
Topic
Health Policy & Regulatory, Health Service Delivery & Process of Care
Topic Subcategory
Health Disparities & Equity, Prescribing Behavior, Pricing Policy & Schemes, Treatment Patterns and Guidelines
Disease
Systemic Disorders/Conditions